Protagonist Therapeutics (PTGX)
(Delayed Data from NSDQ)
$25.15 USD
+0.49 (1.99%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $25.11 -0.04 (-0.16%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | 2.51 |
EPS Last Quarter | 0.44 |
Last EPS Surprise | 375.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.18 |
Next Year | -0.97 |
EPS (TTM) | -1.49 |
P/E (F1) | 20.90 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 300.00M | NA | 236.25M | 149.73M |
# of Estimates | 2 | NA | 4 | 4 |
High Estimate | 300.00M | NA | 335.00M | 330.00M |
Low Estimate | 300.00M | NA | 10.00M | 48.90M |
Year ago Sales | 0.00M | 0.00M | 60.00M | 236.25M |
Year over Year Growth Est. | NA | NA | 293.75% | -36.62% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.51 | -0.62 | 1.18 | -0.97 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | 3.75 | -0.63 | 2.29 | -1.53 |
High Estimate | 4.33 | -0.56 | 2.35 | 1.20 |
Low Estimate | -0.55 | -0.66 | -2.10 | -2.57 |
Year ago EPS | -0.67 | -0.68 | -1.39 | 1.18 |
Year over Year Growth Est. | 474.63% | 8.82% | 184.89% | -181.92% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.51 | -0.62 | 1.18 | -0.97 |
7 Days Ago | 2.51 | -0.62 | 1.18 | -0.97 |
30 Days Ago | 2.51 | -0.62 | 1.18 | -0.97 |
60 Days Ago | -0.62 | -0.63 | -1.19 | -1.10 |
90 Days Ago | -0.62 | -0.63 | -2.50 | -1.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.51 | -0.62 | 1.18 | -0.97 |
Zacks Consensus Estimate | 2.51 | -0.62 | 1.18 | -0.97 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.44 | -0.58 | -0.68 | -0.67 | NA |
Estimate | -0.16 | -0.68 | -0.65 | -0.69 | NA |
Difference | 0.60 | 0.10 | -0.03 | 0.02 | 0.17 |
Surprise | 375.00% | 14.71% | -4.62% | 2.90% | 97.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more